BIOMAT Database Logo BIOMAT Database Logo

Accumulation of 3-hydroxyquinidine following chronic quinidine therapy. 1991

B H Ackerman, and K M Olsen, and A A Pappas

UI MeSH Term Description Entries
D011802 Quinidine An optical isomer of quinine, extracted from the bark of the CHINCHONA tree and similar plant species. This alkaloid dampens the excitability of cardiac and skeletal muscles by blocking sodium and potassium currents across cellular membranes. It prolongs cellular ACTION POTENTIALS, and decreases automaticity. Quinidine also blocks muscarinic and alpha-adrenergic neurotransmission. Adaquin,Apo-Quinidine,Chinidin,Quincardine,Quinidex,Quinidine Sulfate,Quinora,Apo Quinidine,Sulfate, Quinidine
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

B H Ackerman, and K M Olsen, and A A Pappas
[Chronic renal insufficiency. Elevated levels of the active metabolite (3-hydroxyquinidine) of quinidine].
October 1982, La Nouvelle presse medicale,
B H Ackerman, and K M Olsen, and A A Pappas
The pharmacokinetics and pharmacodynamics of quinidine and 3-hydroxyquinidine.
October 1988, British journal of clinical pharmacology,
B H Ackerman, and K M Olsen, and A A Pappas
Total and unbound concentrations of quinidine and 3-hydroxyquinidine at steady state.
February 1987, American heart journal,
B H Ackerman, and K M Olsen, and A A Pappas
Phenytoin-induced changes in quinidine and 3-hydroxyquinidine pharmacokinetics in conscious dogs.
April 1980, The Journal of pharmacology and experimental therapeutics,
B H Ackerman, and K M Olsen, and A A Pappas
Pharmacodynamics of 3-hydroxyquinidine alone and in combination with quinidine in healthy persons.
March 1987, The American journal of cardiology,
B H Ackerman, and K M Olsen, and A A Pappas
A high-pressure liquid chromatography method for serum quinidine and (3S)-3-hydroxyquinidine.
January 1979, Clinica chimica acta; international journal of clinical chemistry,
B H Ackerman, and K M Olsen, and A A Pappas
Prevalence of high (3S)-3-hydroxyquinidine/quinidine ratios in serum, and clearance of quinidine in cardiac patients with age.
January 1980, Clinical pharmacology and therapeutics,
B H Ackerman, and K M Olsen, and A A Pappas
Determination of quinidine, dihydroquinidine, (3S)-3-hydroxyquinidine and quinidine N-oxide in plasma and urine by high-performance liquid chromatography.
October 1994, Journal of chromatography. B, Biomedical applications,
B H Ackerman, and K M Olsen, and A A Pappas
[Quinidine and enzyme induction. Erroneous interpretation of the plasma levels of 3-hydroxyquinidine and O-demethylquinidine].
January 1984, Therapie,
B H Ackerman, and K M Olsen, and A A Pappas
Specific determination of quinidine and (3S)-3-hydroxyquinidine in human serum by high-pressure liquid chromatography.
November 1977, The Journal of laboratory and clinical medicine,
Copied contents to your clipboard!